MAPT and supranuclear palsy, progressive, 1: Interestingly, low CSF concentrations of t- and, more consistently, p-tau, have been reported in PSP patients, despite the fact that tau pathology plays a significant role in PSP pathogenesis (Magdalinou et al., 2014; Jabbari et al., 2017; Table 1).